| Literature DB >> 25691646 |
Yi-Hsiang Cheng1, Tzu-Lung Lin1, Yi-Jiun Pan1, Yu-Ping Wang2, Yi-Tsung Lin2, Jin-Town Wang3.
Abstract
Colistin is one of the antibiotics of last resort for the treatment of carbapenem-resistant Klebsiella pneumoniae infection. This study showed that capsular type K64 (50%) and ST11 (53.9%) are the prevalent capsular and sequence types in the colistin-resistant strains in Taiwan. The interruption of transcripts (38.5%) and amino acid mutation (15.4%) in mgrB are the major mechanisms contributing to colistin resistance. In addition, novel single amino acid changes in MgrB (Stop48Tyr) and PhoQ (Leu26Pro) were observed to contribute to colistin resistance.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25691646 PMCID: PMC4394772 DOI: 10.1128/AAC.04763-14
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191